Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_assertion type Assertion NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_head.
- NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_assertion description "[An 18-year-old man had cystic fibrosis (CF) and insulin-resistant carbohydrate intolerance characterized by (1) obesity, basal hyperinsulinemia, and hyperglucagonemia; (2) impaired oral glucose tolerance; (3) hyperinsulinemia in response to oral and intravenous (IV) administration of glucose and to IV administration of tolbutamide; (4) exaggerated gastric inhibitory polypeptide secretion following orally administered glucose; and (5) diminished sensitivity to insulin administered IV compared with other patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_provenance.
- NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_assertion evidence source_evidence_literature NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_provenance.
- NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_assertion SIO_000772 6375349 NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_provenance.
- NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_assertion wasDerivedFrom befree-20150227 NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_provenance.
- NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_assertion wasGeneratedBy ECO_0000203 NP512915.RASbeOCwd65QV93Us0qdUAyNcTWx1vSSvC022ruqt3e08130_provenance.